Senkottuvelan Kadirvel

RNAi-mediated silencing of hepatic <i>Alas1</i> effectively prevents and treats the induced acute attacks in acute intermittent porphyria mice

Makiko Yasuda, Lin Gan, Brenden Chen et al. · Proceedings of the National Academy of Sciences · 2014 · 126 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +17

Liver Transplantation for Acute Intermittent Porphyria: Biochemical and Pathologic Studies of the Explanted Liver

Makiko Yasuda, Angelika Erwin, Lawrence U. Liu et al. · Molecular Medicine · 2015 · 67 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

X-linked macrocytic dyserythropoietic anemia in females with an ALAS2 mutation

Vijay G. Sankaran, Jacob C. Ulirsch, Vassili Tchaikovskii et al. · Journal of Clinical Investigation · 2015 · 46 citations · Full text

Life Sciences, Genetics, Hematology +17

The carboxyl-terminal region of erythroid-specific 5-aminolevulinate synthase acts as an intrinsic modifier for its catalytic activity and protein stability

Senkottuvelan Kadirvel, Kazumichi Furuyama, Hideo Harigae et al. · Experimental Hematology · 2012 · 29 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +15

The common HAQ STING allele prevents clinical penetrance of COPA syndrome

Noa Simchoni, Shogo Koide, Maryel Likhite et al. · The Journal of Experimental Medicine · 2024 · 14 citations · Full text

Life Sciences, Genetics, Molecular Genetics +13